Litcius/Paper detail

Biomarkers for antimicrobial stewardship: a reappraisal in COVID-19 times?

Miranda van Berkel, Matthijs Kox, Tim Frenzel, Peter Pickkers, Jeroen Schouten, on behalf of the RCI-COVID-19 study group, Miranda van Berkel, Matthijs Kox, Tim Frenzel, Peter Pickkers, Jeroen Schouten, Denise Waanders, Niklas Bruse, Emma J. Kooistra, Hugo Touw, Pleun Hemelaar, Remi Beunders, Johannes van der Hoeven, Sjef van der Velde, Hetty van der Eng, Noortje Rovers, Margreet Klop-Riehl, Jelle Gerretsen, Nicole Waalders, Wout J. Claassen, Hidde Heesakkers, Tirsa van Schaik, Mihai G. Netea, Leo A. B. Joosten, Nico Janssen, Inge Grondman, Aline de Nooijer, Quirijn de Mast, Martin Jaeger, Ilse J.E. Kouijzer, Helga Dijkstra, Heidi Lemmers, Reinout van Crevel, Josephine van de Maat, Gerine Nijman, Simone J.C.F.M. Moorlag, Esther Taks, Priya A. Debisarun, Heiman Wertheim, Joost Hopman, Janette Rahamat‐Langendoen, Chantal P. Bleeker‐Rovers, Esther Fasse, Esther van Rijssen, Manon Kolkman, Bram van Cranenbroek, Ruben L. Smeets, Irma Joosten

2020Critical Care74 citationsDOIOpen Access PDF

Abstract

Contains fulltext : 229373.pdf (Publisher’s version ) (Open Access)

Topics & Concepts

MedicineAntimicrobial stewardshipCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakMEDLINEPandemicIntensive care medicineVirologyInternal medicineAntibiotic resistanceAntibioticsMicrobiologyInfectious disease (medical specialty)OutbreakLawDiseasePolitical scienceBiologyAntibiotic Use and ResistanceCOVID-19 Clinical Research StudiesNosocomial Infections in ICU
Biomarkers for antimicrobial stewardship: a reappraisal in COVID-19 times? | Litcius